BLTE:NASDAQ
Belite Bio Inc
$153.67
arrow_downward
-0.69%(-1.07) 1D
$153.67
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BLTE...
Open
$155.08
High
$157.00
Low
$150.67
Mkt. cap
6.19B
Avg. vol.
160.18K
Volume
114.88K
52-wk high
$200.00
52-wk low
$102.00
EPS
-$2.85
Beta
-1.23
Shares outstanding
40.27M
No. of employees
41
Open
$155.08
High
$157.00
Low
$150.67
Mkt. cap
6.19B
Avg. vol.
160.18K
Volume
114.88K
52-wk high
$200.00
52-wk low
$102.00
EPS
-$2.85
Beta
-1.23
Shares outstanding
40.27M
No. of employees
41
News stories
From web sources and news partners
Foreign Policy Journal
·
35 minutes ago
RTX Corporation's (NYSE: RTX) $271 Billion Backlog Fuels Analyst Optimism Despite Engine Concerns
Dealroom
·
39 minutes ago
Agility Robotics clears SPAC vote, expects $465M and Nasdaq debut November 5
investingLive
·
8 minutes ago
JPMorgan’s four midterm scenarios: S&P 500 seen moving between -0.25% and +1.25%
Bloomberg.com
·
4 hours ago
Nasdaq 100 Enters Correction as Megacap Results Amplify AI Fears
About Belite Bio Inc
Analyst ratings
Based on 7 analysts giving stock ratings to BLTE in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BLTE in the last 3 months.
Highest
Current $153.67
$303.00 (+97.18%)
Average
$235.00 (+52.93%)
Lowest
$200.00 (+30.15%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Graig Suvannavejh Mizuho Securities | Buy | Maintained | $221.00 | +43.8% | 10/29/2026 |
Yi Chen H.C. Wainwright | Buy | Reiterated | $245.00 | +59.4% | 10/15/2026 |
Whitney Ijem Canaccord Genuity | Buy | Initiated | $303.00 | +97.2% | 09/04/2026 |
Tazeen Ahmad Bank of America Securities | Buy | Maintained | $200.00 | +30.1% | 09/02/2026 |
Judah Frommer Morgan Stanley | Buy | Maintained | $206.00 | +34.1% | 08/17/2026 |
Michael Okunewitch Maxim Group | Buy | Maintained | $200.00 | +30.1% | 08/14/2026 |
Steven Seedhouse Cantor Fitzgerald | Buy | Maintained | $270.00 | +75.7% | 08/14/2026 |
Bruce Jackson Benchmark Co. | Buy | Maintained | $217.00 | +41.2% | 03/03/2026 |
Next call in 7 days
Mon, Nov 9, 4:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / -$0.77
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | - | - | - | - |
Cost of goods sold | - | - | - | - |
Cost of revenue | - | - | - | - |
Research and development expenses | 10.31M | 14.62M | 15.66M | 18.21M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 12.71M | 13.45M | 17.02M | 16.69M |
Operating expense | 23.02M | 28.08M | 32.68M | 34.91M |
Total operating expenses | 23.02M | 28.08M | 32.68M | 34.91M |
Operating income | -23.02M | -28.08M | -32.68M | -34.91M |
Other non operating income | -2.14M | -417.00K | 5.75M | 6.55M |
EBT including unusual items | -21.69M | -25.32M | -26.94M | -28.36M |
EBT excluding unusual items | -21.69M | -25.32M | -26.94M | -28.36M |
Income tax expense | - | - | - | 55.00K |
Effective tax rate | - | - | - | -0.19% |
Other operating expenses | - | - | - | - |
Net income | -21.69M | -25.32M | -26.94M | -28.41M |
Net profit margin | - | - | - | - |
Earnings per share | -0.65 | -0.70 | -0.68 | -0.70 |
Interest and investment income | 3.47M | 3.17M | - | - |
Interest expense | - | -2.00K | - | - |
Net interest expenses | 3.47M | 3.17M | - | - |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -22.97M | -28.03M | -32.64M | -34.86M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events